|
World Health Organization WHO
(2022)
C_WHO
|
|
|
Feraud, Dr. Hugo
Ministerio de Salud Argentina
(2022)
C2
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
|
|
|
Vygen-Bonnet S, Koch J, Bogdan C, et al.
(2022)
C1
Tags: 
Impfungen,
COVID-19,
Strategie,
Verteilung,
Ethik,
Risikogruppen,
Priorisierung,
Deutschland,
mRNA,
vector-basierter Impfstoff,
Astra Zeneca,
Moderna,
pfizer,
Risiko,
Sinusvenenthrombosen,
Zweitimpfung,
johnson&Johnson,
pediatrics,
Children,
Adolescents,
booster,
|
|
|
World Health Organization WHO
(2022)
C_WHO
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
|
|
|
Organización Mundial de Saude and OPAS
OPAS
(2021)
C_WHO
|
|
|
Food and Drug Administration
(2021)
CC
|
|
|
World Health Organization WHO, Regional Office of Europe
(2021)
C_WHO
|
|
|
World Health Organization WHO, Regional Office of Europe
(2021)
C_WHO
|
|
|
World Health Organization WHO, Regional Office of Europe
(2021)
C_WHO
|
|
|
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
|
|